FIELD: medicine. SUBSTANCE: method involves injecting 3% sodium 2-methyl- 7-ethylundecyl-4-sulfate solution into the anterior chamber in the amount of 0.3 ml. EFFECT: improved approximation to pathogenetic process development in human patients.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CREATING EXPERIMENTAL MODEL OF GLAUCOMA IN RATS | 2018 |
|
RU2698017C1 |
| OPHTHALMIC DROP | 1999 |
|
RU2163123C2 |
| METHOD OF CONSTRUCTING A MODEL OF CORNEA CHEMICAL BURN | 1995 |
|
RU2119685C1 |
| METHOD FOR TREATING CATARACT AGGRAVATED BY OPEN ANGLE GLAUCOMA | 1998 |
|
RU2173549C2 |
| VISCOELASTIC AGENT FOR PROTECTING EYE TISSUES | 2003 |
|
RU2250100C1 |
| CRYOSURGERY DEVICE | 1996 |
|
RU2118514C1 |
| AGENT FOR TREATMENT OF TRAUMATIC INFECTIONS OF EYE ANTERIOR PART | 1996 |
|
RU2142288C1 |
| METHOD OF TREATING GLAUCOMA AT TERMINAL STAGE OF DISEASE | 2007 |
|
RU2359646C2 |
| VISCOELASTIC FOR PROTECTION OF INTRAOCULAR EYE TISSUES | 2004 |
|
RU2278656C1 |
| METHOD FOR EVALUATING RESISTIVE BED REACTIVITY IN ORBITAL ARTERY POOL IN PATIENTS SUFFERING FROM UNCOMPENSATED GLAUCOMA FORMS | 1998 |
|
RU2173956C2 |
Authors
Dates
2001-03-27—Published
1998-07-16—Filed